GUGGENHIME ANDREW

Track

Insider profile

GUGGENHIME ANDREW's trades of Vaxcyte Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
140.52
Quantity 44,580 -21.1%
Value US$2,725,048
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
442.94
Quantity 8,871 +43.8%
Value US$3,778,110
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
163.55
Quantity 13,242
Value US$464,734
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
57.76
Quantity 2,087 -2.0%
Value US$120,553
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
57.16
Quantity 7,913 -6.9%
Value US$452,283
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
57.76
Quantity 10,000
Value US$577,600
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
53.00
Quantity 10,000 -8.7%
Value US$530,000
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
53.00
Quantity 10,000
Value US$530,000
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
84.58
Quantity 1,818 -1.6%
Value US$153,766
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
83.64
Quantity 6,182 -5.3%
Value US$517,056
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
102.08
Quantity 8,000
Value US$816,640
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
87.70
Quantity 683 -0.6%
Value US$59,899
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
87.25
Quantity 1,999 -1.8%
Value US$174,407
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
86.08
Quantity 5,318 -4.5%
Value US$457,795
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
86.06
Quantity 8,000
Value US$688,480
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
90.24
Quantity 280 -0.3%
Value US$25,267
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
89.31
Quantity 3,157 -2.8%
Value US$281,958
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
88.70
Quantity 3,373 -2.9%
Value US$299,188
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
87.26
Quantity 1,190 -1.0%
Value US$103,835
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
89.83
Quantity 8,000
Value US$718,640
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
87.05
Quantity 132 -0.1%
Value US$11,491
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
86.49
Quantity 1,757 -1.6%
Value US$151,956
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
85.60
Quantity 6,111 -5.2%
Value US$523,071
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
86.50
Quantity 8,000
Value US$692,000
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
116.19
Quantity 5,886 -6.1%
Value US$683,900
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
115.26
Quantity 36,114 -27.3%
Value US$4,162,608
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
115.88
Quantity 42,000
Value US$4,866,960
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
117.53
Quantity 829 -0.9%
Value US$97,433
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
116.29
Quantity 1,686 -1.8%
Value US$196,065
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
115.60
Quantity 5,485 -5.6%
Value US$634,052
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
116.75
Quantity 8,000
Value US$934,000
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
79.14
Quantity 3,006 -3.0%
Value US$237,880
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
78.25
Quantity 4,994 -4.8%
Value US$390,771
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
78.91
Quantity 8,000
Value US$631,280
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
83.14
Quantity 926 -0.9%
Value US$76,985
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
82.32
Quantity 1,479 -1.5%
Value US$121,747
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
81.06
Quantity 2,500 -2.5%
Value US$202,638
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
80.12
Quantity 3,095 -3.0%
Value US$247,956
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
81.68
Quantity 8,000
Value US$653,440
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
72.56
Quantity 348 -0.4%
Value US$25,249
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
71.89
Quantity 7,652 -7.3%
Value US$550,125
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
72.10
Quantity 8,000
Value US$576,800
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
75.46
Quantity 4,456 -4.4%
Value US$336,250
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
75.46
Quantity 4,456 -4.4%
Value US$336,250
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
74.40
Quantity 3,544 -3.4%
Value US$263,659
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-05 2026-08-03
US Vaxcyte Inc (PCVX)
PlS Planned sale
44,580 -21.1%
140.52
US$2,725,048 		44,580 -21.1% 140.52 US$2,725,048
2026-08-05 2026-08-03
US Vaxcyte Inc (PCVX)
PlS Planned sale
8,871 +43.8%
442.94
US$3,778,110 		8,871 +43.8% 442.94 US$3,778,110
2026-08-03 2026-08-03
US Vaxcyte Inc (PCVX)
PrS Proposed sale
13,242
163.55
US$464,734 		13,242 163.55 US$464,734
2026-07-06 2026-07-06
US Vaxcyte Inc (PCVX)
PlS Planned sale
2,087 -2.0%
57.76
US$120,553 		2,087 -2.0% 57.76 US$120,553
2026-07-06 2026-07-06
US Vaxcyte Inc (PCVX)
PlS Planned sale
7,913 -6.9%
57.16
US$452,283 		7,913 -6.9% 57.16 US$452,283
2026-07-06 2026-07-06
US Vaxcyte Inc (PCVX)
PrS Proposed sale
10,000
57.76
US$577,600 		10,000 57.76 US$577,600
2026-06-18 2026-06-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
10,000 -8.7%
53.00
US$530,000 		10,000 -8.7% 53.00 US$530,000
2026-06-18 2026-06-18
US Vaxcyte Inc (PCVX)
PrS Proposed sale
10,000
53.00
US$530,000 		10,000 53.00 US$530,000
2025-02-19 2025-02-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
1,818 -1.6%
84.58
US$153,766 		1,818 -1.6% 84.58 US$153,766
2025-02-19 2025-02-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
6,182 -5.3%
83.64
US$517,056 		6,182 -5.3% 83.64 US$517,056
2025-02-18 2025-02-18
US Vaxcyte Inc (PCVX)
PrS Proposed sale
8,000
102.08
US$816,640 		8,000 102.08 US$816,640
2025-01-22 2025-01-21
US Vaxcyte Inc (PCVX)
PlS Planned sale
683 -0.6%
87.70
US$59,899 		683 -0.6% 87.70 US$59,899
2025-01-22 2025-01-21
US Vaxcyte Inc (PCVX)
PlS Planned sale
1,999 -1.8%
87.25
US$174,407 		1,999 -1.8% 87.25 US$174,407
2025-01-22 2025-01-21
US Vaxcyte Inc (PCVX)
PlS Planned sale
5,318 -4.5%
86.08
US$457,795 		5,318 -4.5% 86.08 US$457,795
2025-01-21 2025-01-21
US Vaxcyte Inc (PCVX)
PrS Proposed sale
8,000
86.06
US$688,480 		8,000 86.06 US$688,480
2024-12-19 2024-12-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
280 -0.3%
90.24
US$25,267 		280 -0.3% 90.24 US$25,267
2024-12-19 2024-12-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
3,157 -2.8%
89.31
US$281,958 		3,157 -2.8% 89.31 US$281,958
2024-12-19 2024-12-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
3,373 -2.9%
88.70
US$299,188 		3,373 -2.9% 88.70 US$299,188
2024-12-19 2024-12-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
1,190 -1.0%
87.26
US$103,835 		1,190 -1.0% 87.26 US$103,835
2024-12-18 2024-12-18
US Vaxcyte Inc (PCVX)
PrS Proposed sale
8,000
89.83
US$718,640 		8,000 89.83 US$718,640
2024-11-19 2024-11-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
132 -0.1%
87.05
US$11,491 		132 -0.1% 87.05 US$11,491
2024-11-19 2024-11-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
1,757 -1.6%
86.49
US$151,956 		1,757 -1.6% 86.49 US$151,956
2024-11-19 2024-11-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
6,111 -5.2%
85.60
US$523,071 		6,111 -5.2% 85.60 US$523,071
2024-11-18 2024-11-18
US Vaxcyte Inc (PCVX)
PrS Proposed sale
8,000
86.50
US$692,000 		8,000 86.50 US$692,000
2024-10-22 2024-10-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
5,886 -6.1%
116.19
US$683,900 		5,886 -6.1% 116.19 US$683,900
2024-10-22 2024-10-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
36,114 -27.3%
115.26
US$4,162,608 		36,114 -27.3% 115.26 US$4,162,608
2024-10-18 2024-10-18
US Vaxcyte Inc (PCVX)
PrS Proposed sale
42,000
115.88
US$4,866,960 		42,000 115.88 US$4,866,960
2024-09-19 2024-09-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
829 -0.9%
117.53
US$97,433 		829 -0.9% 117.53 US$97,433
2024-09-19 2024-09-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
1,686 -1.8%
116.29
US$196,065 		1,686 -1.8% 116.29 US$196,065
2024-09-19 2024-09-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
5,485 -5.6%
115.60
US$634,052 		5,485 -5.6% 115.60 US$634,052
2024-09-18 2024-09-18
US Vaxcyte Inc (PCVX)
PrS Proposed sale
8,000
116.75
US$934,000 		8,000 116.75 US$934,000
2024-08-20 2024-08-19
US Vaxcyte Inc (PCVX)
PlS Planned sale
3,006 -3.0%
79.14
US$237,880 		3,006 -3.0% 79.14 US$237,880
2024-08-20 2024-08-19
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,994 -4.8%
78.25
US$390,771 		4,994 -4.8% 78.25 US$390,771
2024-08-19 2024-08-19
US Vaxcyte Inc (PCVX)
PrS Proposed sale
8,000
78.91
US$631,280 		8,000 78.91 US$631,280
2024-07-22 2024-07-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
926 -0.9%
83.14
US$76,985 		926 -0.9% 83.14 US$76,985
2024-07-22 2024-07-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
1,479 -1.5%
82.32
US$121,747 		1,479 -1.5% 82.32 US$121,747
2024-07-22 2024-07-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
2,500 -2.5%
81.06
US$202,638 		2,500 -2.5% 81.06 US$202,638
2024-07-22 2024-07-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
3,095 -3.0%
80.12
US$247,956 		3,095 -3.0% 80.12 US$247,956
2024-07-18 2024-07-18
US Vaxcyte Inc (PCVX)
PrS Proposed sale
8,000
81.68
US$653,440 		8,000 81.68 US$653,440
2024-06-20 2024-06-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
348 -0.4%
72.56
US$25,249 		348 -0.4% 72.56 US$25,249
2024-06-20 2024-06-18
US Vaxcyte Inc (PCVX)
PlS Planned sale
7,652 -7.3%
71.89
US$550,125 		7,652 -7.3% 71.89 US$550,125
2024-06-18 2024-06-18
US Vaxcyte Inc (PCVX)
PrS Proposed sale
8,000
72.10
US$576,800 		8,000 72.10 US$576,800
2024-05-22 2024-05-20
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,456 -4.4%
75.46
US$336,250 		4,456 -4.4% 75.46 US$336,250
2024-05-22 2024-05-20
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,456 -4.4%
75.46
US$336,250 		4,456 -4.4% 75.46 US$336,250
2024-05-22 2024-05-20
US Vaxcyte Inc (PCVX)
PlS Planned sale
3,544 -3.4%
74.40
US$263,659 		3,544 -3.4% 74.40 US$263,659